These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3299587)

  • 1. The metabolism of aluminum and aluminum-related encephalopathy.
    Mayor GH; Burnatowska-Hledin M
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):1-4. PubMed ID: 3299587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum and the pathogenesis of dialysis encephalopathy.
    Arieff AI
    Am J Kidney Dis; 1985 Nov; 6(5):317-21. PubMed ID: 3904424
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired renal function and aluminum metabolism.
    Mayor GH; Burnatowska-Hledin MA
    Fed Proc; 1983 Oct; 42(13):2979-83. PubMed ID: 6617895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminium encephalopathy.
    Bates D; Parkinson IM; Ward MK; Kerr DN
    Contrib Nephrol; 1985; 45():29-41. PubMed ID: 3979053
    [No Abstract]   [Full Text] [Related]  

  • 6. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalopathy in childhood secondary to aluminum toxicity.
    Sedman AB; Wilkening GN; Warady BA; Lum GM; Alfrey AC
    J Pediatr; 1984 Nov; 105(5):836-8. PubMed ID: 6502319
    [No Abstract]   [Full Text] [Related]  

  • 8. Aluminum, parathyroid hormone, and osteomalacia.
    Burnatowska-Hledin MA; Kaiser L; Mayor GH
    Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and toxicity of aluminum in renal failure.
    Alfrey AC; Hegg A; Craswell P
    Am J Clin Nutr; 1980 Jul; 33(7):1509-16. PubMed ID: 7395774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic encephalopathies: clinical, biochemical, and experimental features.
    Mahoney CA; Arieff AI
    Am J Kidney Dis; 1982 Nov; 2(3):324-36. PubMed ID: 6756130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis encephalopathy syndrome.
    Alfrey AC
    Annu Rev Med; 1978; 29():93-8. PubMed ID: 348053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum binding to organic acids and plasma proteins. Implications for dialysis encephalopathy.
    Trapp GA
    J Environ Pathol Toxicol Oncol; 1985; 6(1):15-20. PubMed ID: 4067831
    [No Abstract]   [Full Text] [Related]  

  • 16. Onset of dialysis encephalopathy in cyclosporine-treated renal allograft recipients.
    Hawley CM; Rigby RJ; Boyle RS; Petrie JJ
    Am J Kidney Dis; 1990 Apr; 15(4):364-8. PubMed ID: 2321647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dialysis dementia syndrome and aluminum intoxication.
    Sideman S; Manor D
    Nephron; 1982; 31(1):1-10. PubMed ID: 7110469
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful treatment of progressive dialysis encephalopathy. Case report].
    Weiland P; Köhler M; Glatzel E
    Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum metabolism and toxicity in renal failure: a review.
    Mayor GH; Lohr TO; Sanchez TV
    J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysis encephalopathy: a review.
    Jack R; Rabin PL; McKinney TD
    Int J Psychiatry Med; 1983-1984; 13(4):309-26. PubMed ID: 6368440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.